Abstract
The great versatility of G protein-coupled receptors (GPCRs), in terms of both their ability to bind different types of ligands and initiate a large number of distinct cellular signaling events, remains incompletely understood. In recent years, the classical view of the nature and consequences of ligand binding to GPCRs has dramatically changed. The notion of functional selectivity, achieved through both biased ligands and allosteric modulators, has brought substantial new insight into our comprehension of the pluridimensionality of signaling achieved by GPCRs. Moreover, receptor heterodimerization adds another important dimension to the diversity of cellular responses controlled by GPCRs. Here, we review these considerations and discuss how they will impact the design of improved therapeutics.
Keywords: GPCR, ligand-directed signaling, functional selectivity, biased ligand, allosterism, dimer, rhodopsin, Neutral Antagonist, Allosteric modulator, Bitopic ligand, metabotropic glutamate receptors
Mini-Reviews in Medicinal Chemistry
Title:Functional Selectivity in GPCR Signaling: Understanding the Full Spectrum of Receptor Conformations
Volume: 12 Issue: 9
Author(s): E. Goupil, S. A. Laporte and T. E. Hebert
Affiliation:
Keywords: GPCR, ligand-directed signaling, functional selectivity, biased ligand, allosterism, dimer, rhodopsin, Neutral Antagonist, Allosteric modulator, Bitopic ligand, metabotropic glutamate receptors
Abstract: The great versatility of G protein-coupled receptors (GPCRs), in terms of both their ability to bind different types of ligands and initiate a large number of distinct cellular signaling events, remains incompletely understood. In recent years, the classical view of the nature and consequences of ligand binding to GPCRs has dramatically changed. The notion of functional selectivity, achieved through both biased ligands and allosteric modulators, has brought substantial new insight into our comprehension of the pluridimensionality of signaling achieved by GPCRs. Moreover, receptor heterodimerization adds another important dimension to the diversity of cellular responses controlled by GPCRs. Here, we review these considerations and discuss how they will impact the design of improved therapeutics.
Export Options
About this article
Cite this article as:
Goupil E., A. Laporte S. and E. Hebert T., Functional Selectivity in GPCR Signaling: Understanding the Full Spectrum of Receptor Conformations, Mini-Reviews in Medicinal Chemistry 2012; 12 (9) . https://dx.doi.org/10.2174/138955712800959143
DOI https://dx.doi.org/10.2174/138955712800959143 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Triggers and Anatomical Substrates in the Genesis and Perpetuation of Atrial Fibrillation
Current Cardiology Reviews Neuropeptide/Receptor Expression and Plasticity in Micturition Pathways
Current Pharmaceutical Design Kernel-Based Feature Selection Techniques for Transport Proteins Based on Star Graph Topological Indices
Current Topics in Medicinal Chemistry Applicability of Monocyte Activation Test for Pyrogen Detection in Succinylated Gelatin Injection
Current Pharmaceutical Analysis The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders
Current Medicinal Chemistry - Central Nervous System Agents Contribution of NRF2 in Gastrointestinal Protection from Oxidative Injury
Current Pharmaceutical Design Interstitial Lung Disease Associated with Collagen Vascular Disease
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Curcumin Conjugates and Metallocomplexes as Lead Compounds for Development of Anticancer Agents - A Short Review
Current Bioactive Compounds Macrolides Allergy
Current Pharmaceutical Design Nanoparticles Adjuvants in Allergology: New Challenges and Pitfalls
Current Pharmaceutical Design Current Highlights About the Safety of Inorganic Nanomaterials in Healthcare
Current Medicinal Chemistry Caspase-8 as a Regulator of Tumor Cell Motility
Current Molecular Medicine Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine
Current Drug Safety Genes Involved in Hereditary Hearing Impairment
Current Genomics Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy Resveratrol Effects on Molecular Pathways and MicroRNAs in Gastrointestinal Cancers
Current Medicinal Chemistry Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Vascular Remodelling and Angiogenesis in Asthma: Morphological Aspects and Pharmacological Modulation
Inflammation & Allergy - Drug Targets (Discontinued) Lipoplexes Formulation and Optimisation: In Vitro Transfection Studies Reveal No Correlation with In Vivo Vaccination Studies
Current Drug Delivery The Role of Progenitor Cells in Osteoarthritis Development and Progression
Current Stem Cell Research & Therapy